Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Successful treatment with entecavir for reactivation of hepatitis B virus following systemic chemotherapy in a hepatitis B surface antigen-negative patient with colorectal cancer.
Okagawa Y, Takada K, Hisai H, Koshiba Y, Wada H, Miyazaki E, Kanari Y, Kawano Y, Iyama S, Hayashi T, Sato T, Sato Y, Miyanishi K, Kobune M, Takimoto R, Kato J. Okagawa Y, et al. Intern Med. 2014;53(16):1759-62. doi: 10.2169/internalmedicine.53.1970. Epub 2014 Aug 15. Intern Med. 2014. PMID: 25130106 Free article.
RNAi-mediated gene silencing of ST6GalNAc I suppresses the metastatic potential in gastric cancer cells.
Tamura F, Sato Y, Hirakawa M, Yoshida M, Ono M, Osuga T, Okagawa Y, Uemura N, Arihara Y, Murase K, Kawano Y, Iyama S, Takada K, Hayashi T, Sato T, Miyanishi K, Kobune M, Takimoto R, Kato J. Tamura F, et al. Among authors: okagawa y. Gastric Cancer. 2016 Jan;19(1):85-97. doi: 10.1007/s10120-014-0454-z. Epub 2014 Dec 23. Gastric Cancer. 2016. PMID: 25532910
A dose-escalation study of oxaliplatin/capecitabine/irinotecan (XELOXIRI) and bevacizumab as a first-line therapy for patients with metastatic colorectal cancer.
Sato Y, Ohnuma H, Hirakawa M, Takahashi M, Osuga T, Okagawa Y, Murase K, Takada K, Kawano Y, Iyama S, Hayashi T, Sato T, Miyanishi K, Takimoto R, Kobune M, Okita K, Mizuguchi T, Furuhata T, Hirata K, Kato J. Sato Y, et al. Among authors: okagawa y. Cancer Chemother Pharmacol. 2015 Mar;75(3):587-94. doi: 10.1007/s00280-014-2672-9. Epub 2015 Jan 11. Cancer Chemother Pharmacol. 2015. PMID: 25577134 Clinical Trial.
A Phase 1/2 Study of Definitive Chemoradiation Therapy Using Docetaxel, Nedaplatin, and 5-Fluorouracil (DNF-R) for Esophageal Cancer.
Ohnuma H, Sato Y, Hirakawa M, Okagawa Y, Osuga T, Hayashi T, Sato T, Miyanishi K, Kobune M, Takimoto R, Sagawa T, Hori M, Someya M, Nakata K, Sakata K, Takayama T, Kato J. Ohnuma H, et al. Among authors: okagawa y. Int J Radiat Oncol Biol Phys. 2015 Oct 1;93(2):382-90. doi: 10.1016/j.ijrobp.2015.05.041. Epub 2015 Jun 3. Int J Radiat Oncol Biol Phys. 2015. PMID: 26232855 Clinical Trial.
Relationship Between Increased Fucosylation and Metastatic Potential in Colorectal Cancer.
Osuga T, Takimoto R, Ono M, Hirakawa M, Yoshida M, Okagawa Y, Uemura N, Arihara Y, Sato Y, Tamura F, Sato T, Iyama S, Miyanishi K, Takada K, Hayashi T, Kobune M, Kato J. Osuga T, et al. Among authors: okagawa y. J Natl Cancer Inst. 2016 Apr 13;108(8):djw038. doi: 10.1093/jnci/djw038. Print 2016 Aug. J Natl Cancer Inst. 2016. PMID: 27075853 Free PMC article.
47 results